RNLX Stock Rises; Could It Be Tied to US FDA’s Approval?  

RNLX Stock Rises; Could It Be Tied to US FDA’s Approval?  

1
Renalytix PLC (NASDAQ: RNLX) stock reflected an impressive upper trend after its KidneyIntelX.dkd prognostic testing platform was approved.
2
RNLX stock price reflected an unusual upper movement of 41.75%.   
Renalytix PLC (NASDAQ: RNLX) stock price impressed the market on the June 30 trading session when its prices jumped more than 43%. It opened trading at $2.89, dipped to $2.59, hit a high of $3.37, and closed trading at $2.92 with an intraday trading volume of 32.561 Million. 
In the past week, RNLX stock price reflected an unusual upper movement of 41.75%, and stock prices jumped more than 34% monthly. …
 

Czytaj więcej

We współpracy z: https://www.thecoinrepublic.com/2023/07/03/rnlx-stock-rises-could-it-be-tied-to-us-fdas-approval/

Total
0
Shares
Dodaj komentarz

Podobne Wpisy